N-G-METHYL-L-ARGININE, AN INHIBITOR OF NITRIC-OXIDE FORMATION, ACTS SYNERGISTICALLY WITH DOBUTAMINE TO IMPROVE CARDIOVASCULAR PERFORMANCE IN ENDOTOXEMIC DOGS
Rg. Kilbourn et al., N-G-METHYL-L-ARGININE, AN INHIBITOR OF NITRIC-OXIDE FORMATION, ACTS SYNERGISTICALLY WITH DOBUTAMINE TO IMPROVE CARDIOVASCULAR PERFORMANCE IN ENDOTOXEMIC DOGS, Critical care medicine, 22(11), 1994, pp. 1835-1840
Objective: To evaluate the hemodynamic effects of the nitric oxide inh
ibitor, N-G-methyl-L-arginine, and dobutamine during experimental endo
toxemia. Design: Prospective, randomized, controlled animal study. Set
ting: University research laboratory. Subjects: Adult, male mongrel do
gs. Interventions: After catheterization with a flow-directed, thermal
-dilution puhnonary artery flotation catheter and arterial catheter, a
wake dogs received either N-G-methyl-L-arginine or dobutamine alone or
in combination (controls; n = 5). Other animals were administered end
otoxin (50 mu g/kg), then received either N-G-methyl-L-arginine alone
or in combination with dobutamine after the onset of hypotension (endo
toxin-treated; n = 5). Measurements and Main Results: Both dobutamine
and N-G-methyl-L-arginine alone had a small, but significant vasopress
or effect on control animals. In contrast, administration of the combi
nation of N-G-methyl-L-arginine and dobutamine resulted in a 48.6% inc
rease in mean arterial pressure, an effect which was dose-dependent wi
th respect to N-G-methyl-L-arginine. In dogs treated with 50 mu g/kg o
f endotoxin, hypotension could be only partially reversed by N-G-methy
l-L-arginine, mainly due to a decline in cardiac output. Co-infusion o
f dobutamine reversed this depression of cardiac output and resulted i
n a complete restoration of blood pressure. Conclusions: Later stages
of septic shock are characterized by hypotension and decreased myocard
ial performance. A major mediator of hypotension is nitric oxide, a va
sodilatory agent derived from L-arginine. Administration of the argini
ne derivative, N-G-methyl-L-arginine, improved systemic vascular resis
tance but not myocardial performance. The addition of an inotropic age
nt to N-G-methyl-L-arginine, a nitric oxide synthase inhibitor, result
ed in an enhancement of the antihypotensive action of N-G-methyl-L-arg
inine through the restoration of cardiac output. The synergistic actio
n between dobutamine and N-G-methyl-L-arsnine may be of therapeutic va
lue in the treatment of septic shock.